Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?
J Thorac Oncol
.
2021 Oct;16(10):e77.
doi: 10.1016/j.jtho.2021.06.018.
Authors
Zafer Arık
1
,
Mustafa Erman
2
Affiliations
1
Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: drzaferarik@gmail.com.
2
Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
PMID:
34561037
DOI:
10.1016/j.jtho.2021.06.018
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Follow-Up Studies
Humans
Lung Neoplasms*
Substances
ErbB Receptors